Author

P. Pathmendra

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Assay:DNA methylation· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

J. A. Byrne· 2 shared A. Capes Davis· 1 shared A. Lee· 1 shared C. Labbe· 1 shared D. J. Oste· 1 shared F. J. Enguita· 1 shared G. Cabanac· 1 shared G. Johnson· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. A. Byrne

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Misspellings or miscellings- non-verifiable cell lines in cancer research publications

D. J. Oste, P. Pathmendra, R. A. K. Richardson, G. Johnson, Y. Ao, M. D. Arya, N. R. Enochs, M. Hussein, J. Kang, A. Lee, J. J. Danon, G. Cabanac, C. Labbe, A. Capes Davis, T. Stoeger, J. A. Byrne

The paper identifies non-verifiable human cell lines in cancer research publications, finding 235 papers referring to 7 cell lines as independent entities despite lacking proper documentation.

bioRxiv · Feb 29, 2024Cancer Biology

Verification of nucleotide sequence reagent identities in original publications in high impact factor cancer research journals

P. Pathmendra, Y. Park, F. J. Enguita, J. A. Byrne

This study verifies nucleotide sequence reagents in high-impact cancer journals and finds 3.8% and 4.3% of sequences are wrongly identified in Molecular Cancer and Oncogene papers, respectively.

bioRxiv · Feb 3, 2023Cancer Biology